Medicinal Cannabis Scheme guideline and forms

Published online: 
06 April 2020

Part 1: Licensing Scheme Overview

  • Part 1 will be available soon

This document provides an overview of the Medicinal Cannabis Scheme’s regulatory and licensing regime, and outlines the types of licences that can be issued for medicinal cannabis and the purpose of each licence activity.

Part 2: Information for New Zealand Manufacturers and Packers

This document provides prospective manufacturers and packers of medicinal cannabis products with relevant information about:

  • the Licence to Manufacture Medicines and the Licence to Pack Medicines under the Medicines Act 1981
  • how to comply with the New Zealand Code of Good Manufacturing Practice for Manufacture and Distribution of Therapeutic Goods.

Part 3: Guidance for a New Medicinal Cannabis Product Application

This document outlines how to make an application for a new medicinal cannabis product.

Part 4: Guidance for Applicants for a Medicinal Cannabis Licence

This document provides guidance on applying for a Medicinal Cannabis Licence under the Misuse of Drugs Act 1975 (the Act) and the Misuse of Drugs (Medicinal Cannabis) Regulations 2019 (the Regulations).

While we have made every effort here to explain the scope of the information that you need to provide in your application, it is your responsibility to understand your obligations under the Act and Regulations and provide true and accurate information in your application.

Please send all correspondence about your application to [email protected]

Part 5: Guidance for a Changed Medicinal Cannabis Product Application

  • Part 5 will be available soon

This document outlines the application and evidence requirements for approval from the Medicinal Cannabis Agency to make a planned change to a medicinal cannabis product or cannabis-based ingredient listed on a current licence.

Forms

Form A: Application for a Medicinal Cannabis Licence

Form D: Declaration of illicit seed and plants

NCMP Application Form: Application for assessment of a New Medicinal Cannabis Product

Publishing information

Back to top